A test of targeted drugs plus immune cell therapy for children with DIPG or neuroblastoma
Original title: PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early safety test in people.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests targeted drugs given with cells made from the child's own body.
Who this trial is for. This trial is for children with newly found DIPG, and for children whose neuroblastoma has come back. It tests drugs aimed at the tumor, given along with immune cells and stem cells taken from the child's own body.
Where it stands. The trial has not reported results. It is checking how safe this plan is, whether it can be carried out, and the highest dose children can handle. Those answers are not in yet.
What this means, and what it doesn't
What it could mean: A family whose child fits this picture could ask their care team about this study. The work may help doctors learn whether this approach is safe enough to test further.
What it doesn't mean: This does not mean the treatment works. A trial is a test, not proven care. Joining one is not a promise that it will help. It is not a cure.
Source: ClinicalTrials.gov, November 4, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.